[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
July 14, 1999

Gabapentin for Postherpetic Neuralgia—Reply

JAMA. 1999;282(2):134-135. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-2-jbk0714

In Reply: Drs Colman and Stadel write that providing AE data that are determined by the investigator to be related to the study medication is to filter these data. However, in the case of a medication that has been on the market for almost 5 years and has been prescribed to more than 2 million patients (unpublished data, 1998), associated AEs provide for a more meaningful data set by providing an AE profile that the health care professional can reasonably expect to encounter when prescribing this medication.

First Page Preview View Large
First page PDF preview
First page PDF preview
×